CBD oil has surged in popularity across the UK, with over 6 million people, or 11% of the population, having used it in the past year.
Though CBD oil seems like a recent trend, the cannabis plant has a long history, dating back 12,000 years, and has been used globally for millennia as a natural remedy for stress and pain relief, with Emperor Sheng Nong of China even developing a cannabis-based medicinal tea in 2737 BC.
In the last century, advancements in organic chemistry have allowed CBD to be isolated from the cannabis plant, leading to its mass production and a global market valued at $4.95 billion in 2023, with an impressive annual growth rate of 26%.
The UK Medicines and Healthcare products Regulatory Agency categorizes CBD oil as a food, meaning manufacturers can't claim medical benefits, yet many users have shared positive reviews, reporting improvements in mood, pain relief, and sleep quality from CBD oils, balms, gummies, and creams.
Although more research is needed to fully understand CBD oil's benefits, studies have shown promising results, particularly for epilepsy. In 2018, the FDA approved Epidiolex, a purified CBD drug, for treating epilepsy disorders like Dravet and Lennox-Gastaut syndromes, with clinical trials showing it can significantly reduce seizure frequency in patients unresponsive to conventional treatments.
"Wishing all our valued partners, clients, and colleagues a Merry Christmas and a joyful holiday season from the VPLUS team! May the new year bring success, growth, and continued collaboration."
Dec 18, 2024
The lung’s delicate surfactant layer is of critical importance to the organ’s overall physiology and innate immune function. Both alveolar type II cells and alveolar macrophages are the principal subsets that maintain and catabolize surfactant at the liquid-air interface. Our study reveals that ENDS exposure disrupts both the lipid and protein components of pulmonary surfactant, […]
Dec 12, 2024
Neurodegenerative diseases leading to Parkinson's disease (PD) and Alzheimer's disease (AD) have become a major global health burden. Current treatments are mainly aimed at controlling symptoms, and there are no effective treatments in clinical practice to prevent neurodegeneration or induce neuronal repair. Therefore, the need for new research on these two diseases is urgent. The […]
Dec 05, 2024
Sativex® (nabiximols) is an oromucosal cannabinoid drug that contains 2.7 mg THC and 2.5 mg CBD per spray. It has been approved by regulators in 29 countries for the treatment of spasticity in multiple sclerosis. The medical application of cannabis began very early. From the mid-19th century to the 20th century, it was used by […]
Nov 26, 2024
Ultrasonic atomization uses ultrasonic directional pressure to make the liquid surface bulge, and cavitation occurs around the bulging liquid surface, causing the liquid to be atomized into small molecular mist. The oscillation frequency of the ultrasonic atomizer is 1.7MHz or 2.4MHz, which exceeds the human hearing range. The electronic oscillation is harmless to humans and […]
Nov 21, 2024